Company intelligence / Profile preview

Peijia Medical

Suzhou, Jiangsu Province, Chinapeijiamedical.com ↗

Ownership: Private
Employees: ~1047
Development stage: Commercial

Overview

Peijia Medical has developed and commercialized several high-end interventional medical devices for structural heart disease and neurovascular intervention. Its TaurusTrio TAV System recently received approval for registration in China. The company’s pipeline includes both marketed products and those under regulatory review or clinical development

Therapeutic areas: CardiovascularNeurology
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

3 assets

TaurusElite

Commercial

Indications: Aortic valve disease

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Peijia Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peijia Medical.

Explore the full profile